{
  "docId": "019dd923-622c-750b-8b9a-ad0811d3e80d",
  "docSlug": "dfcef8f28a20",
  "documentTitle": "Accelerate Diagnostics (AXDX)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-09-16 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 30,
  "pageCount": 41,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "preempt_rebuttal",
  "function": "preempt_rebuttal",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "Includes a direct quote from Lawrence Mehren (CEO) to support the argument.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "numbered_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-ad0811d3e80d/30",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d#slide-30",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "AXDX appears to understand this as well, downplaying the significance of Mayo-UCLA study outcomes:",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b3a1-c027a7adac31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.1,
        "y": 0.7
      },
      "kind": "list",
      "text": "1. Mehren hinted that with the Mayo/UCLA study, the Pheno system likely won't show an improvement in Length Of Stay (LOS) and mortality rate. 2. Reagent revenues per Pheno system were below the company's target projections. 3. Pheno system placements were below expectations.",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "506f5646-735a-4063-b01c-70f611b3b4b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.1,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "study was underpowered with only 203 patients. Despite that, the difference in time to first escalation for gram-positive infection came really close to a statistical significance with p=0.0557.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9649dc12-e63c-405b-bd9a-15b8fbf46bb4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.8,
        "x": 0.1,
        "y": 0.21
      },
      "kind": "paragraph",
      "text": "Will a statistically significant reduction of time to optimal therapy be critical for the adoption of the Pheno system? We believe it will not, because without proven improvements in the mortality rate and LOS...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0fbe351-6e36-4da7-bd9b-84ee9718750b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.1,
        "y": 0.48
      },
      "kind": "quote",
      "text": "The Mayo study should readout in the first half and as it relates to our placements -- while the successful outcome on the Mayo study could provide additional tailwind, it's not required for us to achieve the 300 to 400 placements that we've guided to.",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab8c1b94-720e-4d03-8408-3bcdbcfe54cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "The Mayo study should readout in the first half and as it relates to our placements -- while the successful outcome on the Mayo study could provide additional tailwind, it's not required for us to achieve the 300 to 400 placements that we've guided to. — Lawrence Mehren",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b3a1-c7a2f1cfae4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.1,
        "y": 0.6
      },
      "kind": "title",
      "text": "AXDX's Q2 19 Analyst Call Confirms Our Bearish Thesis",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55fa9436-c78e-4969-b8fc-bc65c2aca7d5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 41,
      "from": 30,
      "beatId": "ca57db9c-677e-4ef8-919c-92b1690ee48e",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document implies that the solution is to be cautious of the system's limitations and avoid investment in AXDX, citing a potential decline in AXDX shares.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}